SCHEMBL5222370

SCHEMBL5222370

CCNc1cc(C(=O)NC(Cc2ccccc2)C(CNC(C)(C)c2cccc(OC)c2)OC=O)cc(N2CCCC2=O)c1

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.69
CTSD P07339 19/20 0.69
BACE2 Q9Y5Z0 18/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL5222365 0.91 BACE1 (0.79) BACE1CTSDBACE2
SCHEMBL5223127 0.91 BACE1 (0.83) BACE1CTSDBACE2
SCHEMBL5222019 0.89 CTSD (0.83) BACE1CTSDBACE2
SCHEMBL5218617 0.86 CTSD (0.73) BACE1CTSDBACE2
SCHEMBL5222127 0.83 CTSD (0.88) BACE1CTSDBACE2
SCHEMBL5222132 0.83 CTSD (0.88) BACE1CTSDBACE2
SCHEMBL5221611 0.83 CTSD (0.82) BACE1CTSDBACE2
SCHEMBL5220596 0.83 CTSD (0.82) BACE1CTSDBACE2
SCHEMBL5222386 0.82 BACE1 (0.71) BACE1CTSDBACE2
SCHEMBL5219470 0.82 CTSD (1.00) BACE1CTSDBACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed